Simeprevir for the treatment of hepatitis C virus infection

Simeprevir (TMC435, Olysio™), a second-generation hepatitis C virus (HCV) protease inhibitor, has been recently approved for the treatment of genotype 1 chronic hepatitis C in combination with pegylated interferon and ribavirin. This molecule has very different characteristics from first-generation...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Izquierdo, Laure, Helle, François, François, Catherine, Castelain, Sandrine, Duverlie, Gilles, Brochot, Etienne
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2014
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4157399/
https://ncbi.nlm.nih.gov/pubmed/25206310
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S52715
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller